340B covered entity representatives are scrambling to respond to a U.S. House subcommittee’s unanimous approval yesterday of a bill that includes language that would make it impossible nationally for entities to earn revenue from billing state Medicaid managed care contractors above what they pay for 340B-acquired drugs.
The so called “spread pricing” language was in an amendment that the Energy & Commerce health subcommittee attached yesterday to H.R. 3281, the Transparent PRICE Act, a bill focused mainly on requiring hospitals and health insurance companies to make charges and prices more accessible. It then passed the bill 27-0 and sent it to the full committee for action maybe as soon as next week.
340B covered entity representatives are scrambling to respond to a U.S. House subcommittee’s unanimous approval yesterday of a bill that includes language that would make it impossible nationally for entities to earn revenue from billing state Medicaid managed care contractors […]
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.